Compliance Rate
Compliance Rate
0.0%
Compliant submissions
0
Incompliant submissions
1
Total trials
1
My Organizations' Clinical Trials
Showing 1275 of 1404 entries
View as:
Phase: N/A
Priority: Normal
Start: 08/31/11
End: 07/31/13
Due: 07/31/14
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 07/31/06
Due: 07/31/07
Phase: N/A
Priority: Normal
Start: 05/23/22
End: 03/30/24
Due: 03/30/25
Phase: N/A
Priority: Normal
Start: 08/02/16
End: 04/07/17
Due: 04/07/18
Phase: N/A
Priority: Normal
Start: 10/02/18
End: 04/15/22
Due: 04/15/23
Phase: N/A
Priority: Normal
Start: 04/30/16
End: 12/31/16
Due: 12/31/17
Phase: N/A
Priority: Normal
Start: 02/22/17
End: 08/01/21
Due: 08/01/22
Phase: N/A
Priority: Normal
Start: 09/30/03
End: 08/31/17
Due: 08/31/18
Phase: N/A
Priority: Normal
Start: 01/11/18
End: 04/15/21
Due: 04/15/22
Phase: N/A
Priority: Normal
Start: 07/31/09
End: 05/31/11
Due: 05/31/12
Phase: N/A
Priority: Normal
Start: 07/31/15
End: 09/30/15
Due: 09/30/16
Phase: N/A
Priority: Normal
Start: 08/24/17
End: 04/13/18
Due: 04/13/19
Phase: N/A
Priority: Normal
Start: 12/08/21
End: 01/25/23
Due: 01/25/24
Phase: N/A
Priority: Normal
Start: 06/30/25
End: 11/30/26
Due: 11/30/27
Initial Assessment of an Internet-based Symptom Management Intervention in Early Stage Breast Cancer
Phase: N/A
Priority: Normal
Start: 06/30/15
End: 06/30/16
Due: 06/30/17
Phase: N/A
Priority: Normal
Start: 01/25/23
End: 06/30/26
Due: 06/30/27
Phase: N/A
Priority: Normal
Start: 02/11/23
End: 07/31/25
Due: 07/31/26
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 05/31/15
Due: 05/31/16
Phase: N/A
Priority: Normal
Start: 06/24/19
End: 09/20/19
Due: 09/20/20
Phase: N/A
Priority: Normal
Start: 04/30/02
End: 10/31/16
Due: 10/31/17
Phase: N/A
Priority: Normal
Start: 09/30/11
End: 11/30/14
Due: 11/30/15
Phase: N/A
Priority: Normal
Start: 05/31/15
End: 10/31/18
Due: 10/31/19
Phase: N/A
Priority: Normal
Start: 03/31/11
End: 11/30/13
Due: 11/30/14
Phase: N/A
Priority: Normal
Start: 11/30/06
End: 02/29/08
Due: 02/28/09
Phase: N/A
Priority: Normal
Start: 09/15/22
End: 07/20/23
Due: 07/20/24